Literature DB >> 11735238

A study of the growth-promoting and metabolic effects of growth hormone (GH) in a patient with the "growth without GH" syndrome.

M Pavlou1, A Tsatsoulis, Z Efstathiadou, S Bitsis, Z L Papadopoulou.   

Abstract

The paradox of normal or even excessive growth despite a proven lack of GH is a well-known but still unexplained phenomenon that has been described in some patients following resection of a craniopharyngioma or other suprasellar tumours. However, the consequences of GH deficiency on other metabolic aspects of GH action in this syndrome have not been adequately investigated. The aim of this study was to examine whether a dissociation might exist between the growth-promoting and metabolic effects of GH. We studied a 7.1 year old boy who, after removal of a suprasellar craniopharyngioma, developed panhypopituitarism with mild hyperprolactinaemia. Despite the presence of severe GH deficiency associated with persistently low IGF-I and IGFBP-3 levels, the patient grew spontaneously at an accelerated rate for a prepubertal boy, achieving a height velocity of 9.0 cm during the first and 8.5 cm during the second post-operative year. However, other metabolic parameters of GH activity were adversely affected by the lack of GH. The maximum tubular reabsorption rate for phosphate over glomerular filtration rate ratio (2.8) was persistently low and normalized during a 4 day course of hGH administration (4.2) together with the normalization of IGF-I (from 34 microg/l to 294 microg/l), suggesting that GH-dependent renal phosphate handling is impaired in this syndrome. In addition, bone age was delayed by 1.7 years consistently with delayed skeletal maturation, whereas skinfold thickness and the waist to hip ratio were increased in comparison with normative data, suggesting increased adipose tissue mass with central fat distribution, a phenotype characteristic of GH deficiency. In conclusion, our case study suggests that, in the "growth without GH" syndrome, the excessive growth is independent of GH and dissociated from other GH-dependent metabolic effects, which are decreased. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735238     DOI: 10.1054/ghir.2001.0204

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  5 in total

1.  Hyperinsulinemia may promote growth without GH in children after resection of suprasellar brain tumors.

Authors:  Hideyuki Iwayama; Takashi Kamijo; Norishi Ueda
Journal:  Endocrine       Date:  2011-06-03       Impact factor: 3.633

2.  Untreated hypopituitarism due to absence of the pituitary stalk with normal adult height: report of two cases.

Authors:  Leda Papastathopoulou; Marinella Tzanela; Vania Vlassopoulou; Dimitra Vassiliadi; Nikolaos Thalassinos
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors.

Authors:  Go Hun Seo; Jin-Ho Choi; Yoon-Myung Kim; Kyung-Nam Koh; Ho Joon Im; Young Shin Ra; Han-Wook Yoo
Journal:  J Neurooncol       Date:  2018-01-19       Impact factor: 4.130

4.  Growth without growth hormone in combined pituitary hormone deficiency caused by pituitary stalk interruption syndrome.

Authors:  Sang Soo Lee; A-Leum Han; Moon Bae Ahn; Shin Hee Kim; Won Kyoung Cho; Kyoung Soon Cho; So Hyun Park; Min Ho Jung; Byung-Kyu Suh
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-03-31

Review 5.  Slipped capital femoral epiphysis with hypopituitarism in adults: A case report and literature review.

Authors:  Zhixin Niu; Jinshuo Tang; Xianyue Shen; Shenghao Xu; Zhongsheng Zhou; Tong Liu; Jianlin Zuo
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.